Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Depress Anxiety. 2019 May 21;36(8):766–779. doi: 10.1002/da.22913

Table 1. Demographics.

Patients with major depression disorder (MDD, N = 7) and bipolar disorder (BD, N = 6) compared to controls (N = 10). m = male, f = female. HDRS = Hamilton Depression Rating Scale. Medication: escitalopram (20mg/d), fluoxetine (20mg/d), lamotrigine (250mg/d), lithium (1350mg/d), valproic acid (750–1000mg/d).

Subjects Sex Age HDRS Previous
episodes
Medication Race Education
(years)

MDD f 30 1 0 none More than one race 17
MDD f 63 39 3 none Black or African American 21
MDD f 63 23 1 none Black or African American 16
MDD f 63 31 1 none Black or African American 13
MDD f 79 19 1 escitalopram White 18
MDD f 70 26 1 none White 17
MDD m 83 18 0 none White 12

BD f 44 21 0 valproic acid, fluoxetine White 16
BD f 29 23 0 lamotrigine, fluoxetine White 15
BD m 56 19 0 lithium White 16
BD m 45 23 1 valproic acid, fluoxetine Black or African American 17
BD f 23 29 3 valproic acid, fluoxetine White 16
BD m 48 26 0 valproic acid, fluoxetine White 17

Control m 52 0 0 none Black or African American 13
Control f 28 5 0 none White 14
Control m 41 0 0 none White 16
Control f 26 1 0 none Black or African American 19
Control m 23 3 0 none Asian 17
Control f 24 6 0 none White 16
Control f 31 1 0 none Black or African American 16
Control f 28 5 0 none White -
Control f 45 0 0 none White 16
Control f 25 3 0 none Black or African American 16